Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Acceleration of resistance adaptation depends on the strength of selection imposed by previous drug exposures

PROVIDER: PRJNA771356 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16355500_1.fastq.gz	Fastqsanger.gz
	SRR16355500_2.fastq.gz	Fastqsanger.gz
	SRR16355501_1.fastq.gz	Fastqsanger.gz
	SRR16355501_2.fastq.gz	Fastqsanger.gz
	SRR16355502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Escherichia coli K-12 strain:K12

Project description:Acceleration of resistance adaptation depends on the strength of selection imposed by previous drug exposures

| PRJNA769657 | ENA

Evolution of drug resistance in cancer cells involves generation of numerous mutations in non-coding genome that reduces the chances of DNA breaks

Project description:Selection of drug-resistant mammalian cell mutants requires multiple drug exposures. Since cells in starting population could be genetically identical, selection of pre-existent mutations is unlikely. Therefore, adaptation must involve generation of drug-resistant mutations de-novo. Understanding how adaptive mutations are generated and protect cells is important for our knowledge of cancer biology and evolution. Here, we studied adaptation of cancer cells to topoisomerase (Top1) inhibitor irinotecan, which triggers DNA breaks, resulting in cytotoxicity. Resistance mechanism was based on gradual accumulation of recurrent mutations in non-coding DNA at sequence-specific Top1 cleavage sites. Repair of DSBs at these sites following initial irinotecan exposures created mutant sequences that were resistant to further Top1 cleavage. Therefore, by virtue of creating DNA breaks Top1 increases the rate of highly protective mutations specifically at such spots, thus explaining a puzzling need of dose escalation in resistance development.

2021-11-24 | GSE189366 | GEO

Prediction of antibiotic resistance by large-scale phenotypic and genotypic data

Project description:The evolution of antibiotic resistance is a clear example of adaptation by natural selection. Although a number of mutations contributing to the resistance have been identified, the relationship between the mutations and the related phenotypic changes responsible for the resistance has yet to be fully elucidated. To better characterize phenotype-genotype mapping for drug resistance, we performed parallel laboratory evolution of Escherichia coli under the selection of single antibiotics and after 90 days propagation obtained resistant strains. We find that an acquisition of resistance to one drug drastically changes the resistance and susceptibility to other drugs. Based on transcriptome data of these strains, we demonstrated that the resistances could be quantitatively predicted by the expression changes of a small number of genes. Whole-genome resequencing analysis provided several candidate mutations contributing to the resistances, while phenotype-genotype mapping was suggested to be complex and included various mutations that caused similar phenotypic changes. The integration of transcriptome and genome data enables us to extract essential phenotypic changes for drug resistances. To examine the contribution of the gene expression changes to the antibiotic resistances, transcriptome of the parent strain (duplicated) and 40 resistant strains (4 parallel-evolved resistant strains for 10 antibiotics) were analyzed.

2014-09-17 | E-GEOD-59408 | biostudies-arrayexpress

Plasmodium falciparum Dd2

Project description:Malaria in vitro drug resistance selection

| PRJNA242185 | ENA

Plasmodium falciparum Dd2

Project description:Malaria in vitro drug resistance selection

| PRJNA242191 | ENA

Plasmodium falciparum Dd2

Project description:Malaria in vitro drug resistance selection

| PRJNA242192 | ENA

Plasmodium falciparum

Project description:Malaria in vitro drug resistance selection